• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死期间的血栓形成标志物。

Thrombotic markers during myocardial infarction.

作者信息

Ferlito S, Gallina M, Mangiameli S, Chiaranda G

机构信息

Institute of I Medical Clinics, University of Catania, Italy.

出版信息

Panminerva Med. 1995 Sep;37(3):133-6.

PMID:8869368
Abstract

The authors carried out a study on the behavior of some thrombotic molecular "markers" in a group of patients suffering from myocardial infarction, just after the first symptoms and after two weeks from the event. The series consists of 12 subjects (6 males, 6 females, mean age 52 +/- 7), suffering from acute myocardial infarction; just after the first symptoms and instrumental signs (before the thrombolysis) and after two weeks a venous blood withdrawal was done; on the plasma of each sample the determination of fibrinogen (F) (coagulative method), tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), D-dimer (D-D), fibrinopeptide A (FPA) and betathromboglobulin (BTG) (ELISA methods) was performed. The values of t-PA, FPA and BTG did not show remarkable variations; after two weeks from the myocardial infarction compared to the basal values a significant reduction of PAI-1 (4.6 +/- 0.28 UI/ml vs 5.4 +/- 0.33 UI/ml, p < 0.01), D-D (215 +/- 10 ng/ml, vs 253 +/- 12 ng/ml, p < 0.05) and a significant increase of F (294 +/- 28, vs 218 +/- 16 mg%, p < 0.05) were observed. The authors suggest that a basal reduction of the fibrinolytic activity documented by the enhanced PAI-1, may play a major role, influencing pathogenetically the thrombotic event; the other markers seem to be of lower importance, being only secondarily altered in the first phase and gradually returning to a normal pattern after an adequate elapsed time; a preinfarctual hypofibrinolytic condition, probably enhanced by some triggering factor, actually appears the sole prothrombotic system to be counteracted with adequate diet and drug treatments.

摘要

作者对一组心肌梗死患者在首次出现症状后及发病两周后的一些血栓形成分子“标志物”的行为进行了研究。该系列包括12名患有急性心肌梗死的受试者(6名男性,6名女性,平均年龄52±7岁);在首次出现症状和体征后(溶栓前)以及两周后采集静脉血;对每个样本的血浆进行纤维蛋白原(F)(凝固法)、组织纤溶酶原激活物(t-PA)、纤溶酶原激活物抑制剂(PAI-1)、D-二聚体(D-D)、纤维蛋白肽A(FPA)和β-血小板球蛋白(BTG)(酶联免疫吸附测定法)的测定。t-PA、FPA和BTG的值未显示出显著变化;与基础值相比,心肌梗死后两周PAI-1显著降低(4.6±0.28 UI/ml对5.4±0.33 UI/ml,p<0.01),D-D显著降低(215±10 ng/ml对253±12 ng/ml,p<0.05),F显著升高(294±28对218±16 mg%,p<0.05)。作者认为,PAI-1升高所记录的纤溶活性基础降低可能起主要作用,在发病机制上影响血栓形成事件;其他标志物似乎重要性较低,仅在第一阶段继发改变,并在适当时间后逐渐恢复正常模式;梗死前纤溶功能减退状态,可能由某些触发因素增强,实际上似乎是唯一需要通过适当饮食和药物治疗来对抗的促血栓形成系统。

相似文献

1
Thrombotic markers during myocardial infarction.心肌梗死期间的血栓形成标志物。
Panminerva Med. 1995 Sep;37(3):133-6.
2
Haemostatic balance in patients with acute focal cerebral vasculopathy.急性局灶性脑血管病患者的止血平衡
Panminerva Med. 1994 Dec;36(4):184-7.
3
Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.伊洛前列素对重症肢体缺血动脉病变患者进行短期和中期治疗后的血浆促血栓形成标志物
Panminerva Med. 1994 Jun;36(2):76-9.
4
[Hemostatic status in subjects with deep venous thrombosis].[深静脉血栓形成患者的止血状态]
Minerva Cardioangiol. 1996 Dec;44(12):649-53.
5
Ramipril prior to thrombolysis attenuates the early increase of PAI-1 in patients with acute myocardial infarction.在急性心肌梗死患者中,溶栓前使用雷米普利可减轻纤溶酶原激活物抑制剂-1(PAI-1)的早期升高。
Thromb Haemost. 2002 Aug;88(2):180-5.
6
[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].[急性肺血栓栓塞症患者治疗后血液凝血和纤溶系统及肺血管内皮功能的变化]
Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3074-8.
7
[Evaluation of the fibrinolytic system in myocardial infarction].
Sangre (Barc). 1994 Feb;39(1):23-7.
8
[Platelet activation in the early phases of acute myocardial infarction].[急性心肌梗死早期阶段的血小板活化]
Cardiologia. 1998 Aug;43(8):825-32.
9
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?经历过急性心肌梗死的患者与稳定型劳力性心绞痛患者的凝血和纤溶血浆生物标志物有差异吗?
Am Heart J. 2007 Dec;154(6):1059-64. doi: 10.1016/j.ahj.2007.09.015.
10
Prospective double-arm study of fibrinolysis in surgical patients.外科患者纤溶作用的前瞻性双臂研究。
J Surg Res. 1998 Jan;74(1):96-101. doi: 10.1006/jsre.1997.5233.